Balchem (BCPC) Cost of Revenue (2010 - 2026)

Balchem (BCPC) has 17 years of Cost of Revenue data on file, last reported at $21.1 million in Q1 2026.

• Quarterly Cost of Revenue rose 24.64% year-over-year to $21.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.5 million (down 61.04% YoY) and the FY2025 annual result came in at $75.4 million, down 87.79% from the prior year.
• Cost of Revenue grew to $21.1 million in Q1 2026 per BCPC's latest filing, from $20.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $565.3 million in Q4 2023 and bottomed at -$430.6 million in Q4 2022.
• The 5-year median for Cost of Revenue is $19.3 million (2025), against an average of $66.1 million.
• Peak annual rise in Cost of Revenue reached 1036.04% in 2022, while the deepest fall reached 2939.47% in 2022.
• Tracing BCPC's Cost of Revenue over 5 years: stood at -$430.6 million in 2022, then surged by 231.27% to $565.3 million in 2023, then slumped by 72.81% to $153.7 million in 2024, then sank by 86.95% to $20.1 million in 2025, then grew by 5.19% to $21.1 million in 2026.
• Per Business Quant, the three latest BCPC Cost of Revenue figures stand at $21.1 million (Q1 2026), $20.1 million (Q4 2025), and $19.1 million (Q3 2025).

Peer Comparison